Guardant Health, Inc. financial data

Symbol
GH on Nasdaq
Industry
Services-Medical Laboratories
Location
3100 Hanover Street, Palo Alto, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 627 % +2.64%
Quick Ratio 32 % +12.2%
Debt-to-equity 3.92K % +238%
Return On Equity -1.24K % -285%
Return On Assets -30.9 % -20.7%
Operating Margin -74.4 % +22.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 124M shares +4.71%
Common Stock, Shares, Outstanding 123M shares +4.51%
Entity Public Float 4.1B USD +2.5%
Weighted Average Number of Shares Outstanding, Basic 123M shares +4.51%
Weighted Average Number of Shares Outstanding, Diluted 123M shares +4.51%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 692M USD +29.2%
Research and Development Expense 344M USD -10.4%
Selling and Marketing Expense 339M USD +14%
General and Administrative Expense 166M USD +6.34%
Costs and Expenses 1.21B USD +15.1%
Operating Income (Loss) -515M USD -0.35%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -512M USD -19%
Income Tax Expense (Benefit) 27K USD -98.5%
Net Income (Loss) Attributable to Parent -512M USD -18.5%
Earnings Per Share, Basic -4.24 USD/shares -4.18%
Earnings Per Share, Diluted -4.24 USD/shares -4.18%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 585M USD +27.9%
Marketable Securities, Current 870M USD +97.4%
Accounts Receivable, after Allowance for Credit Loss, Current 88.5M USD -0.38%
Inventory, Net 72.3M USD -6.15%
Assets, Current 1.23B USD -8.92%
Property, Plant and Equipment, Net 125M USD -15.2%
Operating Lease, Right-of-Use Asset 145M USD -10.3%
Intangible Assets, Net (Excluding Goodwill) 7.25M USD -25%
Goodwill 3.29M USD 0%
Other Assets, Noncurrent 31.3M USD -75.5%
Assets 1.54B USD -14.4%
Accounts Payable, Current 15.5M USD -80.1%
Accrued Liabilities, Current 71.7M USD -65.1%
Contract with Customer, Liability, Current 29.6M USD +37.6%
Liabilities, Current 197M USD -13%
Contract with Customer, Liability, Noncurrent 3M USD +3.45%
Operating Lease, Liability, Noncurrent 170M USD -11.7%
Other Liabilities, Noncurrent 89.4M USD +778%
Liabilities 1.6B USD +1.91%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.28M USD +42.2%
Retained Earnings (Accumulated Deficit) -2.47B USD -26.2%
Stockholders' Equity Attributable to Parent -60.1M USD -126%
Liabilities and Equity 1.54B USD -14.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.3M USD +59.3%
Net Cash Provided by (Used in) Financing Activities -1.07M USD -25.8%
Net Cash Provided by (Used in) Investing Activities 28.1M USD -82.1%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 123M shares +4.51%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.43M USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 688M USD +50.5%
Deferred Tax Assets, Valuation Allowance 604M USD +23.5%
Deferred Tax Assets, Gross 654M USD +22.4%
Operating Lease, Liability 198M USD -9.83%
Depreciation 40.4M USD +2.8%
Payments to Acquire Property, Plant, and Equipment 6.93M USD -7.84%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -659M USD -50.2%
Lessee, Operating Lease, Liability, to be Paid 226M USD -11%
Property, Plant and Equipment, Gross 282M USD +6.32%
Operating Lease, Liability, Current 27.4M USD +3.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 29.4M USD -11.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 33.7M USD -1.24%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 28.2M USD -18.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25.7M USD -8.64%
Deferred Tax Assets, Operating Loss Carryforwards 344M USD +16.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 36.9M USD +24.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 24.2M USD -0.99%
Additional Paid in Capital 2.41B USD +10.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2.4M USD -14.3%
Depreciation, Depletion and Amortization 10.7M USD +3.55%
Deferred Tax Assets, Net of Valuation Allowance 1.05M USD +107%
Share-based Payment Arrangement, Expense 128M USD +42.4%
Interest Expense 2.58M USD +0.08%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%